Associate Professor at the Department of Medical Biotechnology
Department of Medical Biotechnology,
Faculty of Biochemistry, Biophysics and Biotechnology
Jagiellonian University, Krakow
Agnieszka Jazwa is an associate professor at the Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland. Born in Lancut in Poland, she graduated in medical analytics from Jagiellonian University Medical College in 2002. She undertook a PhD in biochemistry with Professor Jozef Dulak at the Jagiellonian University in 2008.
During her doctoral studies she gained experience in pre-clinical gene therapy research in the laboratory of Professor Seppo Yla-Herttuala at A. I. Virtanen Institute, University of Kuopio and Gene Therapy Unit, Kuopio, Finland and in animal model of hind-limb ischemia in the laboratory of Professor Costanza Emanueli at the Department of Experimental Cardiovascular Medicine, Bristol Heart Institute, Bristol, UK. Following PhD studies in Krakow, she worked for one year as a postdoctoral fellow in the laboratory of Professor Antonio Cuadrado at the Instituto de Investigaciones Biomedicas “Alberto Sols”, Autonomous University of Madrid, Madrid, Spain investigating the neuroprotective effects of Nrf2/HO-1 pathway.
Her current research interests include molecular mechanisms of angiogenesis, vascular biology, role of hypoxia and inflammation in the regulation of gene expression, experimental models of ischemic cardiovascular diseases (limb ischemia, myocardial infarction), role of inflammation and anti-oxidant genes in repair processes after ischemic episodes, gene and cell therapy. She has co-authored more than 20 research and review papers, has held several research grants and is currently coordinating another one.
Her scientific achievements were acknowledged with several awards of the Jagiellonian University and Polish Ministry of Science and Higher Education. She is a member of the Polish Biochemical Society, the Polish Society for Cell Biology and the European Vascular Biology Organization.
EVBO creates a great opportunity for basic and clinical scientists to exchange their knowledge and ideas. This goal is accomplished by organization of international conferences as well as by maintaining an interactive network of researchers with interests in vascular biology. As a PhD student I had an opportunity to present my work at several international meetings. It was for me not only an interesting experience, but also a chance to meet and learn from the greatest scientists in the field of vascular biology and cardiovascular research. EVBO is a society that constantly supports young investigators creating them an opportunity to actively participate in such meetings. By involvement in the EVBO I would develop and promote the main goals of the society among European scientists.